Design and development of a chimeric vaccine candidate against zoonotic hepatitis E and foot-and-mouth disease

• Main Authors: Nouredine Behloul, Sarra Baha, Zhenzhen Liu, Wenjuan Wei, Yuanyuan Zhu, Yuliang Rao, Ruihua Shi, Jihong Meng
• Format: Article
• Language: English
• Published: BMC 2020-07-01
• Series: Microbial Cell Factories
• Subjects: Hepatitis E virus; Foot-and-mouth disease virus; Vaccine design; Chimeric vaccine; Bioinformatics; Immunogenicity
• Online Access: http://link.springer.com/article/10.1186/s12934-020-01394-1

Abstract Background Zoonotic hepatitis E virus (HEV) infection emerged as a serious threat in the industrialized countries. The aim of this study is exploring a new approach for the control of zoonotic HEV in its main host (swine) through the design and development of an economically interesting chimeric vaccine against HEV and against a devastating swine infection: the foot-and-mouth disease virus (FMDV) infection. Results First, we adopted a computational approach for rational and effective screening of the different HEV-FMDV chimeric proteins. Next, we further expressed and purified the selected chimeric immunogens in Escherichia coli (E. coli) using molecular cloning techniques. Finally, we assessed the antigenicity and immunogenicity profiles of the chimeric vaccine candidates. Following this methodology, we designed and successfully produced an HEV-FMDV chimeric vaccine candidate (Seq 8-P222) that was highly over-expressed in E. coli as a soluble protein and could self-assemble into virus-like particles. Moreover, the vaccine candidate was thermo-stable and exhibited optimal antigenicity and immunogenicity properties. Conclusion This study provides new insights into the vaccine development technology by using bioinformatics for the selection of the best candidates from larger sets prior to experimentation. It also presents the first HEV-FMDV chimeric protein produced in E. coli as a promising chimeric vaccine candidate that could participate in reducing the transmission of zoonotic HEV to humans while preventing the highly contagious foot-and-mouth disease in swine.